Peter Anaradian, MD | |
981150 Nebraska Medical Ctr, Omaha, NE 68198-1150 | |
(402) 559-6802 | |
Not Available |
Full Name | Peter Anaradian |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 981150 Nebraska Medical Ctr, Omaha, Nebraska |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518221035 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 6856 (Nebraska) | Primary |
Entity Name | Nebraska Orthopaedic Hospital Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407087489 PECOS PAC ID: 5395645279 Enrollment ID: O20091104000007 |
News Archive
AVEO Pharmaceuticals, Inc. today announced that previously reported positive clinical data evaluating tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC) will be featured in several poster presentations at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17-19, 2011 at the Orlando World Center Marriott in Orlando, Fla.
A new study to assess the effects of U.S.. Food and Drug Administration (FDA) regulations and guidance, intended to encourage greater inclusion of women and minorities in clinical drug trials, has shown appropriate levels of female participation based on the estimated sex ratio of people affected by a particular disease.
As states expand covid-19 vaccine eligibility to allow shots for 16- and 17-year-olds, teens in rural America may have trouble getting them.
Prosolia, Inc. and AB SCIEX announced today that they have entered into a license agreement for technologies developed by Dr. Gary Van Berkel and his colleagues of Oak Ridge National Laboratory.
› Verified 3 days ago
Entity Name | Kearney Regional Medical Center Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174932388 PECOS PAC ID: 7517109408 Enrollment ID: O20141029001548 |
News Archive
AVEO Pharmaceuticals, Inc. today announced that previously reported positive clinical data evaluating tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC) will be featured in several poster presentations at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17-19, 2011 at the Orlando World Center Marriott in Orlando, Fla.
A new study to assess the effects of U.S.. Food and Drug Administration (FDA) regulations and guidance, intended to encourage greater inclusion of women and minorities in clinical drug trials, has shown appropriate levels of female participation based on the estimated sex ratio of people affected by a particular disease.
As states expand covid-19 vaccine eligibility to allow shots for 16- and 17-year-olds, teens in rural America may have trouble getting them.
Prosolia, Inc. and AB SCIEX announced today that they have entered into a license agreement for technologies developed by Dr. Gary Van Berkel and his colleagues of Oak Ridge National Laboratory.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Peter Anaradian, MD 981150 Nebraska Medical Ctr, Omaha, NE 68198-1150 Ph: (402) 559-6802 | Peter Anaradian, MD 981150 Nebraska Medical Ctr, Omaha, NE 68198-1150 Ph: (402) 559-6802 |
News Archive
AVEO Pharmaceuticals, Inc. today announced that previously reported positive clinical data evaluating tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC) will be featured in several poster presentations at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17-19, 2011 at the Orlando World Center Marriott in Orlando, Fla.
A new study to assess the effects of U.S.. Food and Drug Administration (FDA) regulations and guidance, intended to encourage greater inclusion of women and minorities in clinical drug trials, has shown appropriate levels of female participation based on the estimated sex ratio of people affected by a particular disease.
As states expand covid-19 vaccine eligibility to allow shots for 16- and 17-year-olds, teens in rural America may have trouble getting them.
Prosolia, Inc. and AB SCIEX announced today that they have entered into a license agreement for technologies developed by Dr. Gary Van Berkel and his colleagues of Oak Ridge National Laboratory.
› Verified 3 days ago
Tyler Christian Pedersen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Chad E Branecki, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 988095 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-9800 Fax: 402-559-9840 | |
Dr. Robert S. Devin, M.D. Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 6901 N 72nd St, Omaha, NE 68122 Phone: 402-572-2225 Fax: 402-572-4974 | |
Dr. Kevin Michael Montgomery, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Ryan Jorgenson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Phillip Marshall Stratton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4424 Fax: 402-354-4435 | |
Dr. James E Quinn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4424 Fax: 402-354-4435 |